Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/5659
DC FieldValueLanguage
dc.contributor.authorDegenhardt, Louisaen_US
dc.contributor.authorBharat, Chriannaen_US
dc.contributor.authorBruno, Raimondoen_US
dc.contributor.authorGlantz, Meyer Den_US
dc.contributor.authorSampson, Nancy Aen_US
dc.contributor.authorLago, Luiseen_US
dc.contributor.authorAguilar-Gaxiola, Sergioen_US
dc.contributor.authorAlonso, Jordien_US
dc.contributor.authorAndrade, Laura Helenaen_US
dc.contributor.authorBunting, Brendanen_US
dc.contributor.authorCaldas-de-Almeida, Jose Miguelen_US
dc.contributor.authorCia, Alfredo Hen_US
dc.contributor.authorGureje, Oyeen_US
dc.contributor.authorKaram, Elie G.en_US
dc.contributor.authorKhalaf, Mohammaden_US
dc.contributor.authorMcGrath, John Jen_US
dc.contributor.authorMoskalewicz, Jaceken_US
dc.contributor.authorLee, Singen_US
dc.contributor.authorMneimneh, Zeinaen_US
dc.contributor.authorNavarro-Mateu, Fernandoen_US
dc.contributor.authorSasu, Carmen Cen_US
dc.contributor.authorScott, Kateen_US
dc.contributor.authorTorres, Yolandaen_US
dc.contributor.authorPoznyak, Vladimiren_US
dc.contributor.authorChatterji, Somnathen_US
dc.contributor.authorKessler, Ronald Cen_US
dc.date.accessioned2022-05-26T08:03:15Z-
dc.date.available2022-05-26T08:03:15Z-
dc.date.issued2019-
dc.identifier.issn09652140-
dc.identifier.urihttps://scholarhub.balamand.edu.lb/handle/uob/5659-
dc.description.abstractBackground and aims: The World Health Organization’s proposed International Classification of Diseases, 11th Edition (ICD-11) includes several major revisions to substance use disorder (SUD) diagnoses. It is essential to ensure the consistency of within-subject diagnostic findings across countries, languages and cultures. To date, agreement analyses between different SUD diagnostic systems have largely been based in high-income countries and clinical samples rather than general population samples. Design: Face-to-face household surveys. Setting: Representative surveys of the general population in ten countries (Argentina, Australia, Brazil, Colombia, Iraq, Northern Ireland, Poland, Portugal, Romania and Spain) of the World Mental Health Survey Initiative. Participants: Questions about SUDs were asked of 12,182 regular alcohol users and 1,788 cannabis users. Measurements: Analyses examined prevalence of, and concordance between, ICD-11, ICD-10, DSM-5 and DSM-IV diagnoses; prevalence of disaggregated ICD-10 and ICD-11 symptoms; and variation in clinical features across diagnostic groups. Findings: Among regular alcohol users, prevalence (95% confidence interval) of lifetime ICD-11 alcohol harmful use and dependence were 21.6% (20.5%−22.6%) and 7.0% (6.4%−7.7%), respectively. Among cannabis users, 9.3% (7.4%−11.1%) met criteria for ICD-11 harmful use and 3.2% (2.3%−4.0%) for dependence. For both substances, all comparisons of ICD-11 with ICD-10 and DSM-IV showed excellent concordance (all κ≥0.90). Concordance between ICD-11 and DSM-5 ranged from good (for SUD, and comparisons of dependence and severe SUD) to poor (for comparisons of harmful use and mild SUD). Very low endorsement rates were observed for new ICD-11 feature for harmful use (‘harm to others’). Minimal variation in clinical features was observed across diagnostic systems. Conclusions: Though modifications were made to ICD-11, classifications are extremely consistent with ICD-10 and DSM-IV. Concordance between ICD-11 and DSM-5 varies, largely due to low levels of agreement for the ICD harmful use and DSM-5 mild use disorder. Diagnostic validity of self-reported “harm to others” is questionableen_US
dc.language.isoengen_US
dc.subjectAlcoholen_US
dc.subjectDSMen_US
dc.subjectICDen_US
dc.subjectWorld Mental Health Surveysen_US
dc.subjectCannabisen_US
dc.subjectDiagnosisen_US
dc.subjectSubstance use disorderen_US
dc.titleConcordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO's World Mental Health Surveysen_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1111/add.14482-
dc.identifier.pmid30370636-
dc.identifier.scopus2-s2.0-85058185687-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85058185687-
dc.contributor.affiliationFaculty of Medicineen_US
dc.description.volume114en_US
dc.description.issue3en_US
dc.description.startpage534en_US
dc.description.endpage552en_US
dc.date.catalogued2022-05-26-
dc.description.statusPublisheden_US
dc.identifier.openURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059958/en_US
dc.relation.ispartoftextAddictionen_US
dc.description.campusSGH campusen_US
Appears in Collections:Faculty of Medicine
Show simple item record

SCOPUSTM   
Citations

32
checked on Nov 23, 2024

Record view(s)

55
checked on Nov 22, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.